Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
1.570
-0.130 (-7.65%)
At close: Jul 16, 2026, 4:00 PM EDT
1.574
+0.004 (0.25%)
Pre-market: Jul 17, 2026, 4:06 AM EDT
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of $90.91 million as of July 16, 2026. Its market cap has decreased by -34.69% in one year.
Market Cap
90.91M
Enterprise Value
37.25M
1-Year Change
-34.69%
Ranking
Category
Stock Price
$1.57
ChartMarket Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has decreased from $154.10M to $90.91M, a decrease of -41.01%. That is a compound annual growth rate of -5.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 90.91M | -30.77% |
| Dec 31, 2025 | 131.30M | 133.63% |
| Dec 31, 2024 | 56.20M | -27.86% |
| Dec 29, 2023 | 77.90M | -13.06% |
| Dec 30, 2022 | 89.60M | -82.69% |
| Dec 31, 2021 | 517.50M | -1.84% |
| Dec 31, 2020 | 527.20M | 186.68% |
| Dec 31, 2019 | 183.90M | 64.34% |
| Dec 31, 2018 | 111.90M | -33.71% |
| Dec 29, 2017 | 168.80M | 9.54% |
| Nov 2, 2017 | 154.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Verrica Pharmaceuticals | 95.51M |
| Pelthos Therapeutics | 92.83M |
| Inovio Pharmaceuticals | 92.15M |
| Biomea Fusion | 91.10M |
| Heron Therapeutics | 90.10M |
| Alterity Therapeutics | 89.82M |
| Adicet Bio | 86.32M |
| Rallybio | 84.56M |